5 Critical Questions to Ask Before Applying AI to Real-World Data

When analyzing and utilizing real-world data from healthcare systems, nearly every organization claims to leverage AI — from extraction to curation. With numerous overlapping claims in a crowded market, it becomes challenging to identify meaningful differences, evaluate credibility and determine questions to ask when generating real-world evidence.

Real-world evidence has become a vital tool for life sciences organizations to advance treatment development, meet regulatory requirements and shape their clinical trial strategies. However, this heavily relies on both high-quality data and trust in how it was generated. This webinar will provide an insightful discussion to help equip life sciences professionals with the knowledge and tools needed to navigate discussions around applying AI to real-world data from healthcare data sources such as EHR, images and claims.

Join the featured speakers for this webinar, part of the Real-World Data in Action Series, to explore:

• Current challenges in evaluating AI tools for real-world data across EHRs, claims and imaging
• What separates credible AI applications from generic market applications
• Lessons learned from real-world projects that successfully used AI to support regulatory-grade real-world evidence

Register for this webinar to discover the key questions and considerations when applying AI to real-world data for regulatory-ready evidence.

Speakers

Scott Schliebner, Vice President and Global Head, Drug Development Consulting, Novotech

Scott Schliebner is a strategic and innovative drug development executive with 30 years of experience across the biopharma, contract research organization (CRO) and non-profit sectors. Passionate about ensuring the patient voice is incorporated into drug development, Scott emphasizes the importance of patient-focused solutions to reduce the burden of clinical trial participation and accelerate drug development.

Read more...

He serves as a Strategic and Commercial Advisor, belongs to several industry-led Scientific Advisory Boards and holds Board Member roles within the non-profit sector. He regularly speaks on topics such as patient-focused drug development, innovative regulatory strategies, novel approaches to clinical development and multi-stakeholder collaboration to advance drug development.

Scott earned his Master’s degree in Public Health from the University of Utah School of Medicine and completed a Graduate Research Fellowship at the National Institutes of Health/NINDS.

Read Less...

Message Presenter

Mariah Baltezegar, MBA, Vice President and General Manager, Provider Insights, Thermo Fisher Scientific

Mariah Baltezegar serves as the Vice President and General Manager of Provider Insights. She oversees the development and implementation of both short-term and long-term business strategies, playing a key role in expanding the growth of integrated solutions and the go-to-market strategy for PPD’s real-world evidence business. Her global team focuses on delivering customer-centric solutions to answer complex business and research questions through direct-to-provider data collection enabled by a proprietary technology-enabled platform.

Read more...

Over the past 20 years, she has held various positions of increasing responsibility across the Thermo Fisher (PPD) enterprise, all with a strategic focus on improving efficiency through process or technology, improving the study participant and site experience, while ensuring high-quality customer outcomes. Mariah completed her Master of Business Administration at the University of North Carolina, Wilmington and holds a Bachelor’s degree in Psychology with a Minor in Statistics from Winona State University.

Read Less...

Message Presenter

Tim Hoctor, Member of the Board of Advisors and Consultant, Pistoia Alliance & Evolvus

Tim Hoctor has been in the global life science community throughout his career. Starting in the mid-90s at Oracle, Tim joined Molecular Design (MDL) in 1997 and subsequently Elsevier (following MDL’s acquisition) in various technical, product strategy and senior leadership roles, including Vice President of Global Life Science Services.

Read more...

Tim is an advisor to Evolvus, a world-class provider of data and data services to the global life science community and was previously a strategic advisor to inoCells, a cell therapy startup in women’s health. Tim has been a member of the Board of Directors and an advisory board member of the Pistoia Alliance and an active contributor to SABPA (the Sino-American BioPharma Association). Tim also has extensive experience mentoring emerging founders and entrepreneurs in the life science community in the US and Europe.

Read Less...

Message Presenter

Aracelis Torres, PhD, MPH, Senior Vice President of Data & Science, Verana Health

Aracelis Torres, PhD, MPH, is Senior Vice President of Data & Science, where she oversees the Quantitative Sciences team working on rigorous methodology to generate sound scientific evidence from real-world data, as well as the commercial services and operations team that manage client deliverables.

Read more...

Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Before joining Verana Health, she was the Director of Quantitative Sciences at Flatiron Health, where her work focused on the translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real-world endpoints, novel study designs and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis.

Dr. Torres earned her PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health and a BS in Molecular, Cellular and Developmental Biology from Yale University.

Read Less...

Message Presenter